BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Pharm Country

  Vascular Therapeutics’ COLL-R(tm) Demonstrates Potential to Improve AV Graft Patency in Hemodialysis Patients

  November 13, 2008

   · 

  1 min read
• Omnicare, Inc. to Host Analyst/Investor Day

  November 13, 2008

   · 

  1 min read
• BioCapital

  Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009; Novavax Uses Strategies to Create Vaccines for Avian Flu Through Genetically-engineered Virus-like Particles (VLPs)

  November 13, 2008

   · 

  4 min read
• Business

  Astro-Med, Inc. to Hold FY 2009 Third Quarter Financial Results Conference Call on December 4, 2008

  November 13, 2008

   · 

  1 min read
• Business

  Genesis Pharmaceuticals Enterprises, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2009

  November 13, 2008

   · 

  2 min read
• Business

  University of Pittsburgh Medical Center Collaborates With GE Healthcare to Develop International Oncology Centers

  November 13, 2008

   · 

  1 min read
• FDA

  AstraZeneca PLC’s SEROQUEL XR(TM) And SEROQUEL(R) Approved In Europe For New Indications For The Treatment Of Bipolar Disorder

  November 13, 2008

   · 

  6 min read
• Drug Development

  Five Patrys Limited Lead Products Demonstrate Therapeutic Potential As Treatments For Human Cancers

  November 13, 2008

   · 

  4 min read
• BioCapital

  BioReliance CorporationAnnounces that Sarah Sheridan, Ph.D. Will Deliver a Poster Presentation at the 16th Annual European Society of Gene and Cell Therapy Conference

  November 13, 2008

   · 

  1 min read
• Drug Development

  Theratechnologies Inc.: Last Patient Treated in the Extension Phase of the Confirmatory Study Testing Tesamorelin in HIV-Associated Lipodystrophy

  November 13, 2008

   · 

  1 min read